Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
14.21
-0.21 (-1.46%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Keros Therapeutics Employees
Keros Therapeutics had 169 employees as of December 31, 2024. The number of employees increased by 33 or 24.26% compared to the previous year.
Employees
169
Change (1Y)
33
Growth (1Y)
24.26%
Revenue / Employee
$21,006
Profits / Employee
-$1,108,598
Market Cap
576.39M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
KROS News
- 17 days ago - Keros Therapeutics Goes Up For Sale On Heels Of Stockholder Rights Plan - Benzinga
- 17 days ago - Crude Oil Falls Over 4%; Keros Therapeutics Shares Jump - Benzinga
- 18 days ago - Keros Therapeutics adopts 'poison pill' plan - Reuters
- 18 days ago - Keros Therapeutics Announces Review of Strategic Alternatives - GlobeNewsWire
- 4 weeks ago - Keros Therapeutics Announces Initial Topline Results from the Phase 1 Clinical Trial of KER-065 in Healthy Volunteers - GlobeNewsWire
- 2 months ago - Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences - GlobeNewsWire
- 2 months ago - Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 3 months ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Keros Therapeutics, Inc. (KROS) and Encourages Shareholders to Learn More About the Investigation - Accesswire